Abeona Therapeutics (ABEO) Free Cash Flow: 2011-2025
Historic Free Cash Flow for Abeona Therapeutics (ABEO) over the last 14 years, with Sep 2025 value amounting to -$23.7 million.
- Abeona Therapeutics' Free Cash Flow fell 87.59% to -$23.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$82.4 million, marking a year-over-year decrease of 62.87%. This contributed to the annual value of -$58.5 million for FY2024, which is 56.56% down from last year.
- According to the latest figures from Q3 2025, Abeona Therapeutics' Free Cash Flow is -$23.7 million, which was down 9.32% from -$21.7 million recorded in Q2 2025.
- Over the past 5 years, Abeona Therapeutics' Free Cash Flow peaked at -$5.8 million during Q3 2023, and registered a low of -$33.5 million during Q4 2021.
- For the 3-year period, Abeona Therapeutics' Free Cash Flow averaged around -$14.6 million, with its median value being -$13.4 million (2024).
- In the last 5 years, Abeona Therapeutics' Free Cash Flow crashed by 1,939.26% in 2021 and then spiked by 58.16% in 2022.
- Over the past 5 years, Abeona Therapeutics' Free Cash Flow (Quarterly) stood at -$33.5 million in 2021, then spiked by 58.16% to -$14.0 million in 2022, then spiked by 33.85% to -$9.3 million in 2023, then plummeted by 85.13% to -$17.2 million in 2024, then tumbled by 87.59% to -$23.7 million in 2025.
- Its Free Cash Flow was -$23.7 million in Q3 2025, compared to -$21.7 million in Q2 2025 and -$19.8 million in Q1 2025.